News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Conference News AHA 2020 Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON Michael O'Riordan November 15, 2020
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Daily News Which TAVR Device Is Best? Review Tackles Optimal Selection Michael O'Riordan September 09, 2020
News Daily News Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest Shelley Wood August 05, 2020
News Daily News Ablation Cuts A-fib Recurrences, Burden Through 5 Years in CABANA Todd Neale June 23, 2020
News Daily News Opioid Use Still Too High Among Cardiac Surgery Patients Yael L. Maxwell June 19, 2020
News Conference News HRS 2020 Subcutaneous ICD Holds Up Well Against Transvenous Devices Todd Neale May 13, 2020
News Conference News ACC 2020 New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals Michael O'Riordan April 06, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Conference News ACC 2020 Colchicine Cost-effective in Canada, and Even in the US: COLCOT Caitlin E. Cox March 28, 2020
News Conference News ACC 2020 Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry Michael O'Riordan March 19, 2020